2026³â 02¿ù 26ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

NURI SCIENCE Expands into Latin American Market through Exclusive Partnership in Paraguay

Distribution Agreement Signed with Buenos Negocios in Collaboration with Good Neighbors Global Impact Foundation.
´º½ºÀÏÀÚ: 2025-11-27

SEOUL -- NURI SCIENCE Inc., a biotechnology company specializing in livestock reproduction technology, has signed an exclusive distribution agreement with Buenos Negocios S.A., a leading agricultural and livestock distributor in Paraguay. The partnership marks NURI SCIENCE’s official expansion into the Latin American market.

The agreement was established as part of the Livestock Innovation Initiative led by Good Neighbors Global Impact Foundation (GIF), which has supported the overall business design and partnership coordination for the project.

According to projections from the OECD (Organisation for Economic Co-operation and Development) and FAO (Food and Agriculture Organization), the livestock industry in Latin America is valued at approximately USD 400 billion annually. Demand for productivity-enhancing and sustainable livestock solutions is growing rapidly across the region.

Leveraging its biotechnology expertise, NURI SCIENCE will provide its gender-control-based livestock reproduction solutions, ‘WholeMom’ and ‘WholeMan,’ which increase the likelihood of producing female or male offspring based on farmers’ needs. Through this agreement, Buenos Negocios receives exclusive distribution rights in Paraguay and will lead product registration and proof-of-concept (PoC) trials in neighboring markets, including Brazil, Argentina, Uruguay, and Mexico.

With Paraguay as a strategic hub, the two companies plan to jointly pursue technology commercialization and build a regional distribution network across key Latin American markets. NURI SCIENCE will oversee technology provision and quality assurance, while Buenos Negocios will manage local distribution and market operations. Through this collaborative model, both parties aim to establish a stable market entry platform and contribute to a sustainable livestock ecosystem in the region over the mid to long term.

Dongku Kim, CEO of NURI SCIENCE, said, “This partnership is especially meaningful as it marks the first global commercialization of our biotechnology-based gender control technology. Through this collaboration, we aim to enhance productivity and efficiency in Latin America’s livestock industry.”

Byunghee Lee, CEO of Buenos Negocios, commented, “By combining NURI SCIENCE’s technological expertise with our strong local network, we expect to generate tangible results in Paraguay in a short period of time. We will also move quickly to conduct proof-of-concept trials in neighboring countries and expand distribution across Latin America.”

Jinyoung Hyun, CEO of Good Neighbors Global Impact, stated, “This agreement represents a key milestone for the Livestock Innovation Project in Latin America and showcases a new model where a technology company scales within a social economy framework. We will continue to support this initiative so that NURI SCIENCE’s technology contributes to industrial innovation and increased income for local farmers.”

NURI SCIENCE and Buenos Negocios plan to begin product demonstration projects with major farms and research institutions in Paraguay within the year. Starting in 2026, the distribution network will be expanded to neighboring countries. GIF will continue to support the project’s structure and operations, including local regulatory compliance, quality management, and certification systems to help establish a sustainable market environment.



 Àüü´º½º¸ñ·ÏÀ¸·Î

Concept Medical Begins STARS DAPT Trial With First Patient for Abluminus NP Polymer-Free DES
Research From Lenovo Reveals AI Is Paying Off, Yet Most CIOs Aren¡¯t Ready for What Comes Next
Revolutionizing 5G Network Slice Testing: Industry-First Performance Methodology by Ookla and Ericsson
Parse Biosciences Launches Workflow for Immune Repertoire and Transcriptome Analysis
Copeland Advances AI and Digital Strategy with Acquisition of Bueno Analytics
Vestas Secures 390 MW Offshore Order in South Korea
Syngenta to Tackle Global Farm Challenges at WEF, Driving AI Innovation and Open Tech Access for Farmers

 

Philip Morris International Opens Dialogue on the Future of Human Cogn...
Crown Bioscience San Diego Lab Earns CAP Accreditation, Expands Clinic...
Axelspace Signs MoU with Ethiopian Company to Address Social Challenge...
Parse Biosciences and Graph Therapeutics Partner to Build Large Functi...
SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing
Innovative Research Unveils Potential of Pharmaceutically Processed Mi...
Sisvel Launches Wi-Fi Multimode Patent Pool

 


°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..